Beta-talassæmi intermedia og minor
Obstetrik
Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy. (åbner nyt vindue)
Kilde: Acta Haematol 2006;116(4):259-65.
Indekseret: PubMed 17119327
DOI: 10.1159/000095877
https://www.ncbi.nlm.nih.gov/pubmed/17119327 (åbner nyt vindue)
Erythropoietin use in a pregnant Jehovah's Witness with anemia and beta-thalassemia: a case report. (åbner nyt vindue)
Kilde: J Reprod Med 2005;50(2):135-7.
Indekseret: PubMed 15755051
https://www.ncbi.nlm.nih.gov/pubmed/15755051 (åbner nyt vindue)
Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (åbner nyt vindue)
Kilde: Eur J Haematol 1996;56(5):326-8.
Indekseret: PubMed 8641410
https://www.ncbi.nlm.nih.gov/pubmed/8641410 (åbner nyt vindue)
Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (åbner nyt vindue)
Kilde: J Matern Fetal Med 1999;8(1):1-7.
Indekseret: PubMed 10052837
DOI: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O
https://www.ncbi.nlm.nih.gov/pubmed/10052837 (åbner nyt vindue)
Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report. (åbner nyt vindue)
Kilde: Minerva Ginecol 2000;52(1-2):29-31.
Indekseret: PubMed 10851861
https://www.ncbi.nlm.nih.gov/pubmed/10851861 (åbner nyt vindue)